Clinical Trial Update: A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tirzepatide to placebo in type 2 diabetes patients inadequately controlled on insulin glargine, with or without metformin; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2022-01-12